Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi

The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa

Long-term outcomes after AKI in hospitalized patients with COVID-19 Bernardo Marques da Silva, Joana Gameiro, Joana Lei Teixeira, Cláudia Costa, Carolina Branco, João Oliveira, João Bernardo, Filipe Marques, José Agapito Fonseca, José António Lopes